Induced pluripotent stem cells (iPSCs) technology is a great breakthrough in stem cell reprogramming field. They have great potential to differentiate into any cell types to cure diseases, reverse injuries and offer highly targeted therapies to improve health outcomes. iPSCs have generated a lot of interest and research in drug development and cell therapy. Blood cells differentiation from iPSCs paves the way for future development of hematologic diseases and allogeneic transfusion products. With years of experiences and advanced technologies, Creative Biolabs offers various differentiated cell lineages and commercial iPSCs products.
Blood Cells Differentiation from iPSC
« Rabbit RLA Genotyping Intravascular Administration of Liposomes »
Add comment
Comments